Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe page shows the same study details with minor formatting adjustments and an updated last-updated timestamp, and no substantive changes to the study design or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check78 days agoChange Detected- Capitalization normalization: 'Angioimmunoblastic t-cell lymphoma' (lowercase t) merged into the more proper 'Angioimmunoblastic T-cell lymphoma'. - Version update: revision moved from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion update from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.